Cargando…
Spironolactone as a Potential New Treatment to Prevent Arrhythmias in Arrhythmogenic Cardiomyopathy Cell Model
Arrhythmogenic cardiomyopathy (ACM) is a rare genetic disease associated with ventricular arrhythmias in patients. The occurrence of these arrhythmias is due to direct electrophysiological remodeling of the cardiomyocytes, namely a reduction in the action potential duration (APD) and a disturbance o...
Autores principales: | Reisqs, Jean-Baptiste, Moreau, Adrien, Sleiman, Yvonne, Charrabi, Azzouz, Delinière, Antoine, Bessière, Francis, Gardey, Kevin, Richard, Sylvain, Chevalier, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960914/ https://www.ncbi.nlm.nih.gov/pubmed/36836569 http://dx.doi.org/10.3390/jpm13020335 |
Ejemplares similares
-
The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy
por: Reisqs, Jean‐Baptiste, et al.
Publicado: (2022) -
Short QT interval as a harbinger of an arrhythmogenic cardiomyopathy
por: Chevalier, Philippe, et al.
Publicado: (2021) -
Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy
por: Moreau, Adrien, et al.
Publicado: (2021) -
CMR - Late gadolinium enhancement characteristics associated with monomorphic ventricular arrhythmia in patients with non-ischemic cardiomyopathy
por: Rajinthan, Priyanka, et al.
Publicado: (2022) -
Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells
por: Reisqs, J. B., et al.
Publicado: (2023)